1996
DOI: 10.1074/jbc.271.40.24788
|View full text |Cite
|
Sign up to set email alerts
|

Dual Leucine Zipper-bearing Kinase (DLK) Activates p46SAPK and p38 but Not ERK2

Abstract: Because the catalytic domain of dual leucine zipperbearing kinase (DLK) bears sequence similarity to members of the mitogen-activated protein (MAP) kinase kinase kinase subfamily, this protein kinase was investigated for its ability to activate MAP kinase pathways. While work in mammalian systems established the importance of the ERK pathway in signal transduction from RTKs, it has become clear from studies in yeast that multiple mammalian MAPK pathways exist in parallel (50). Using both genetic and biochemica… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
95
0
12

Year Published

1997
1997
2015
2015

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 133 publications
(110 citation statements)
references
References 47 publications
3
95
0
12
Order By: Relevance
“…As such, DLK phosphorylates and activates the dualspecificity MAPKK MKK7 and MKK4, which in turn phosphorylate and activate the MAPK JNK [26,33,34]. Cterminal of the kinase domain DLK has two leucine zipper motifs that mediate protein dimerisation by forming coiledcoil structures [18].…”
Section: Discussionmentioning
confidence: 99%
“…As such, DLK phosphorylates and activates the dualspecificity MAPKK MKK7 and MKK4, which in turn phosphorylate and activate the MAPK JNK [26,33,34]. Cterminal of the kinase domain DLK has two leucine zipper motifs that mediate protein dimerisation by forming coiledcoil structures [18].…”
Section: Discussionmentioning
confidence: 99%
“…Like all members of the MLK family, DLK acts as a key component of the JNK signaling pathway (1,48). Although significant progress has been achieved in the past few years in our understanding of how DLK regulates the JNK pathway, very little is known about the identity of its physiological agonists and the mechanisms responsible for its own regulation.…”
Section: Discussionmentioning
confidence: 99%
“…The small GTPbinding proteins act via various, multiple downstream mitogenactivated protein (MAP) kinase kinase kinases, depending on the cell type, which bind the active GTP-bound form of the small G-proteins and induce JNK activity and transcriptional activation (Lim et al, 1996;Tapon and Hall, 1997;Van Aelst and D'Souza-Schorey, 1997) (for review, see Johnson, 1999). There are several likely intermediates in the signaling cascades linking Cdc42 to the JNK pathway, including the p21-activated kinases (rat p65PAK/PAK1/PAK ␣, PAK-2/PAK ␥, PAK-3/PAK ␤, and PAK4; Bagrodia et al, 1995;Knaus et al, 1995;Manser et al, 1995;Martin et al, 1995;Brown et al, 1996;Abo et al, 1998), the germinal center kinase (GCK; Pombo et al, 1995), the nickinteracting protein (NIK; Su et al, 1997), MEKK1 and MEKK4 (Fanger et al, 1997;Gerwins et al, 1997), plenty of SH3 (POSH) (Tapon et al, 1998), and the mixed lineage kinase family (MLK1, MLK2, MLK3, DLK, LZK) (Dorow et al, 1993;Holzman et al, 1994;Reddy and Pleasure, 1994;Fan et al, 1996;Hirai et al, 1996;Rana et al, 1996;Teramoto et al, 1996;Tibbles et al, 1996;Hirai et al, 1997;Sakuma et al, 1997;Nagata et al, 1998).…”
Section: Abstract: Apoptosis; Cdc42; Mlk3; Signal Transduction; Sympmentioning
confidence: 99%